Showing results (1-10 of 1,109) with videos related to
Sort By:
Pageof 111
Pharmacogenomics|August 15, 2018
Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactationGideon Koren, Asher OrnoyExpert Review of Clinical Pharmacology|January 9, 2018
The role of the placenta in drug transport and fetal drug exposureGideon Koren, Asher OrnoyExpert Opinion on Drug Metabolism & Toxicology|January 19, 2018
Selective serotonin reuptake inhibitor use in pregnant women; pharmacogenetics, drug-drug interactions and adverse effectsAsher Ornoy, Gideon KorenBirth Defects Research|July 18, 2017
Selective Serotonin Reuptake Inhibitors during Pregnancy: Do We Have Now More Definite Answers Related to Prenatal Exposure?Asher Ornoy, Gideon KorenGlobal Pediatric Health|July 31, 2020
Searching for the Fetal Alcohol Behavioral PhenotypeGideon Koren, Asher OrnoyInternational Journal of Molecular Sciences|May 17, 2019
SSRIs and SNRIs (SRI) in Pregnancy: Effects on the Course of Pregnancy and the Offspring: How Far Are We from Having All the Answers?Asher Ornoy, Gideon KorenSeminars in Fetal & Neonatal Medicine|December 11, 2013
Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversyAsher Ornoy, Gideon KorenCurrent Neuropharmacology|October 16, 2020
Gestational Exposure to Serotonin Reuptake Inhibitors and Pregnancy Outcome; Exploring the Role of Bias and ConfoundersGideon Koren, Asher OrnoyCurrent Neuropharmacology|November 27, 2020
The Effects of Drugs used for the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) on Pregnancy Outcome and Breast-feeding: A Critical ReviewAsher Ornoy, Gideon KorenGlobal Pediatric Health|March 1, 2021
Institutionalized Children and the Risk of Fetal Alcohol Spectrum Disorder (FASD); A Primer for Clinicians, Adoption Staff and ParentsGideon Koren, Asher OrnoyPageof 111